×
Enjoying ad-free content?
Since July 1, 2024, we have disabled all ads to improve your reading experience.
This commitment costs us $10,000 a month. Your support can help us fill the gap.
Support us
Our journalism is banned in Russia. We need your help to keep providing you with the truth.

Russian Ruble, Stocks Surge on Vaccine Optimism

Airlines and oil companies top performers as Pfizer announcement on vaccine effectiveness buoys markets.

The ruble is up 6% over the last week. Kirill Zhukov / Moskva News Agency

The Russian ruble and stock market soared Monday, hitting their strongest levels in months as global markets cheered positive news from one of the frontrunners in the coronavirus vaccine race.

American pharma giant Pfizer and German BioNTech said their vaccine, currently in Phase 3 medical trials, was 90% effective in preventing Covid-19 infections. It is the most detailed and promising public update yet published on vaccine effectiveness from one of the handful of vaccines which have undergone widespread testing among volunteers.

The ruble soared by more than 2% against the dollar — a huge movement in the foreign currency markets — to stand at 75.9. That was the currency’s best reading since mid-September. The ruble has now gained almost 6% from where it stood on the eve of the U.S. presidential election. 

Global enthusiasm also helped push the Russian stock market higher. The dollar-denominated RTS index was up 4.3% during Monday afternoon trading in Moscow, while the ruble-based MOEX Index climbed 2.3%.

Russia’s biggest winners were stocks which have suffered heavily this year amid unprecedented shutdowns of the global economy — airlines and oil companies. Best performer Aeroflot had added almost 8% by 4pm Moscow-time, while energy companies Lukoil, Tatneft and Novatek claimed the next three spots on the leaderboard.

“Pandemic-proof stocks are likely to underperform as those that have been battered over the last eight months come back into favor,” said Craig Erlam, senior market analyst at OANDA Europe.

“With Covid wreaking havoc across Europe and the U.S. once again, the Pfizer announcement has provided the lift we’ve all craved,” he added.

Still, Russian gains lagged the market increases across Europe, where the London benchmark FTSE 100 was up by more than 5% and the Eurostoxx 50, which tracks the 50 largest companies based in the Eurozone, added more than 6%.

Before the U.S. presidential elections, investors feared a Joe Biden victory could mean a stricter policy against Russia and potentially harsher sanctions.

The gains came despite coronavirus infections reaching a new peak globally and in Russia in recent days. Russia is now reporting more than 20,000 new infections a day, but authorities have pushed back on any notion that the country will introduce a second lockdown.

A Message from The Moscow Times:

Dear readers,

We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."

These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.

We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.

Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.

By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.

Once
Monthly
Annual
Continue
paiment methods
Not ready to support today?
Remind me later.

Read more